HowardWarrenBrucknerMD

Oncology • Bronx, NY

Physician

Join to view full profile

Dr. Bruckner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bruckner's full profile

Already have an account?

Office
2330 Eastchester Rd
Bronx, NY 10469
Phone+1 718-732-4050

Fax+1 718-881-4445
Is this information wrong?

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1969 - 1970
Lincoln Medical and Mental Health CenterInternship, Internal Medicine, 1966 - 1967
Albert Einstein College of MedicineClass of 1966
Yale-New Haven Medical CenterFellowship, Medical Oncology

Certifications & Licensure

NY State Medical License 1970 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2005-2014

Clinical Trials

Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer Start of enrollment: 2007 Jul 01
Completed
Phase 1, Phase 2
Safety and Efficacy Study Using Rexin-G for Breast Cancer Start of enrollment: 2007 Jul 01
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times.
Howard W Bruckner, Fred Bassali, Elisheva Dusowitz, Daniel Gurell, Abe Book, Robert De Jager> ;Plos One. 2022 Jan 1
4 citations
Tumor protein p53 mutation in archived tumor samples from a 12-year survivor of stage 4 pancreatic ductal adenocarcinoma may predict long-term survival with DeltaRex-G...
Michael A. Morse, Sant P. Chawla, Terence Z. Wong, Howard Bruckner, Frederick L. Hall, Erlinda M. Gordon> ;Molecular and Clinical Oncology. 2021 Jul 8
1 citations
Ileal Adenocarcinoma with Liver Metastasis in Patient with Crohn's Disease: A 9-Year Survival.
Jiten P. Kothadia, Deepa H. Nagaraju, Seymour Katz, Howard Bruckner, Steven H. Itzkowitz, Myron Schwartz> ;Case Reports in Oncological Medicine. 2019 Aug 14
30 citations
A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer.
Sant P. Chawla, Howard Bruckner, Michael A. Morse, Nupur Assudani, Frederick L. Hall, Erlinda M. Gordon> ;Molecular Therapy Oncolytics. 2019 Mar 29
6 citations
Cancer of the Pancreas-Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few.
Avram M. Cooperman, Howard W. Bruckner, Harry Snady, Hillel Hammerman, Andrew Fader, Michael S. Feld, Frank Golier, Tom Rush, Jerome Siegal, Franklin E. Kasmin, Seth A...> ;The Surgical Clinics of North America. 2018 Feb 1
5 citations
Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine Cancer.
Howard W. Bruckner, Daniel Gurell, Azriel Hirschfeld> ;Anticancer Research. 2018 Jan 1
4 citations
Targeted Therapy for Resistant Cholangiocarcinoma with Bevacizumab or Cetuximab Added to Failed Cytotoxic Drug Cores.
Howard W. Bruckner, Azriel Hirschfeld, Myron Schwartz> ;Anticancer Research. 2016 Jan 1
11 citations
Stereotactic radiosurgery plays a critical role in enhancing long-term survival in a patient with pancreatic cancer metastatic to the brain.
Prajwal Rajappa, Konstantinos Margetis, Gabriella Wernicke, Paula S. Ginter, William Cope, David L. Sherr, Ehud Lavi, Robert L. Fine, Theodore H. Schwartz, Howard W Br...> ;Anticancer Research. 2013 Sep 1
Tumor-targeted cancer vaccination (GeneVieve Protocol): A phase I/II study of intravenous Rexin-G and Reximmune-C for chemotherapy-resistant cancers.
Ignacio JG, Bruckner H, Manalo RE, San Juan FS, Baniqued L, Madamba A, Gordon EM, Hall FL> ;J. Clin. Oncol.. 2011-05-20
Multidisciplinary effect of adding docetaxel and mitomycin-C to low-dose multidrug therapy for cholangiocarcinoma.
Bruckner H, Hirschfeld A, Buddaraju S, Stega J, Jahan M, Schwartz ME> ;J. Clin. Oncol.. 2011-05-20
Adding docetaxel and mitomycin-C to low-dose multidrug therapy for pancreatic cancer.
Hirschfeld A, Stega J, Buddaraju S, Jahan M, Bruckner H> ;J. Clin. Oncol.. 2011-05-20
Low-dose sequential multi-drug regimens for advanced pancreatic cancer.
Bruckner H, Simon K, Hrehorovich V> ;J. Clin. Oncol.. 2008-05-20
24 citations
Pathotropic nanoparticles for cancer gene therapy Rexin-G™ IV: Three-year clinical experience
Erlinda M. Gordon, Francisco F. Lopez, Gerardo H. Cornelio, Conrado C. Lorenzo, John P. Levy, Rebecca A. Reed, Liqiong Liu, Howard Bruckner, Frederick L. Hall> ;International Journal of Oncology. 2006 Nov 1
8 citations
Chemotherapeutic management of small bowel adenocarcinoma associated with Crohn's disease.
Howard W Bruckner, V.R Hrehorovich, H.S. Sawhney, S.I Meeus, A.M. Coopeman> ;Journal of Chemotherapy. 2006 Oct 1
Laboratory based low dose combination chemotherapy + bevacizumab for recurrent refractory and unresectable gastric cancer.
Bruckner HW, Hrehorovich VR, Degregorio P> ;J. Clin. Oncol.. 2006-06-20
13 citations
Bevacizumab as Treatment for Chemotherapy-resistant Pancreatic Cancer
Howard W Bruckner, Victor R Hrehorovich, Harinder S Sawhney> ;Anticancer Research. 2005 Sep 1
Multi-drug chemotherapy for pancreatic cancer.
Bruckner HW, Myo M, Zaw K, Filipova O, Heidarian S, Rafiq N, Julliard K> ;J. Clin. Oncol.. 2005-06-01
13 citations
Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP): a highly active novel therapy for metastatic adenocarcinoma of the exocrine ...
Miguel Araneo, Howard W Bruckner, Michael L. Grossbard, David Frager, Peter Homel, Jennifer Marino, Paola DeGregorio, Fariborz Mortazabi, Karam Firoozi, Kumud Jindal, ...> ;Cancer Investigation. 2003 Nov 8
27 citations
ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.
Christian M. Kurbacher, Ottilia Grecu, Ursula Stier, Tobias J. Gilster, Margit-M. Janát, Michael Untch, Gottfried E. Konecny, Howard W. Bruckner, Ian A. Cree> ;Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 2003 Jan 1
2 citations
A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma
Peter Kozuch, Magdalena Petryk, Howard W Bruckner> ;Hematology/oncology Clinics of North America. 2002 Feb 1
75 citations
Irinotecan Combined with Gemcitabine, 5-Fluorouracil, Leucovorin, and Cisplatin (G-FLIP) is an Effective and Noncrossresistant Treatment for Chemotherapy Refractory Me...
Peter Kozuch, Michael L. Grossbard, Atis Barzdins, Miguel Araneo, Abigail Robin, David Frager, Peter Homel, Jennifer Marino, Paola DeGregorio, Howard W. Bruckner> ;The Oncologist. 2001 Dec 1
8 citations
LONG-TERM FOLLOW-UP OF TWENTY PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS Resection Following Combined Modality Therapy
Avram M. Cooperman, Harry Snady, Howard W. Bruckner, Hillel Hammerman, Jerome H. Siegel, Bernard Stark, Simmy Bank> ;The Surgical Clinics of North America. 2001 Jun 1
5 citations
Therapy for regionally unresectable pancreatic cancer.
Peter Kozuch, Magdalena Petryk, Andrew Evans, Howard W. Bruckner> ;The Surgical Clinics of North America. 2001 Jun 1
5 citations
Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.
Peter Kozuch, Magdalena Petryk, Andrew Evans, Howard W. Bruckner> ;The Surgical Clinics of North America. 2001 Jun 1
18 citations
Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients.
Alexander S. Sun, Hsu-Chong Yeh, Lu-Hai Wang, Yun Peng Huang, Hiroshi Maeda, Arman Pivazyan, Ching Hsu, Ellen R. Lewis, Howard W. Bruckner, Thomas M. Fasy> ;Nutrition and Cancer. 2001 Jan 1
Join now to see all

Press Mentions

Noteworthy Oncologist Howard W. Bruckner, MD, FACP, Will Be Displayed in the Leading Physicians of the WorldFebruary 15th, 2017

Grant Support

Therapy Of Patients With Gastric &Pancreatic CarcinomaNational Cancer Institute1985